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Abstract
Background: With the development of new surgical techniques in breast cancer, such as oncoplastic breast
surgery, increased knowledge of risk factors for poor satisfaction with conventional breast-conserving surgery (BCS)
is needed in order to determine which patients to offer these techniques to. The aim of this study was to
investigate patient satisfaction regarding aesthetic result and skin sensitivity in relation to patient, tumour, and
treatment factors, in a consecutive sample of patients undergoing conventional BCS.
Methods: Women eligible for BCS were recruited between February 1, 2008 and January 31, 2012 in a prospective
setup. In all, 297 women completed a study-specific questionnaire 1 year after conventional BCS and radiotherapy.
Potential risk factors for poor satisfaction were investigated using logistic regression analysis.
Results: The great majority of the women, 84%, were satisfied or very satisfied with the overall aesthetic result. The
rate of satisfaction regarding symmetry between the breasts was 68% and for skin sensitivity in the operated breast
it was 67%. Excision of more than 20% of the preoperative breast volume was associated with poor satisfaction
regarding overall aesthetic outcome, as was axillary clearance. A high BMI (≥30 kg/m2) seemed to affect satisfaction
with symmetry negatively. Factors associated with less satisfied patients regarding skin sensitivity in the operated
breast were an excision of ≥20% of preoperative breast volume, a BMI of 25–30 kg/m2, axillary clearance, and
radiotherapy. Re-excision and postoperative infection were associated with lower rates of satisfaction regarding
both overall aesthetic outcome and symmetry, as well as with skin sensitivity.
Conclusions: Several factors affect patient satisfaction after BCS. A major determinant of poor satisfaction in this
study was a large excision of breast volume. If the percentage of breast volume excised is estimated to exceed
20%, other techniques, such as oncoplastic breast surgery, with or without contralateral surgery, or mastectomy
with reconstruction, may be considered.
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Background
Breast-conserving surgery (BCS), i.e. a partial mastectomy,
followed by radiotherapy, is today a common alternative
to mastectomy, when treating early breast cancer.
One intention, when choosing BCS, is to optimize the
aesthetic result. Surgical techniques have been developed to
improve the aesthetic outcome, while maintaining onco-
logical safety, i.e. oncoplastic breast surgery [1, 2]. However,
use of these techniques requires specially trained breast
surgeons and, with certain procedures, the participation of
a plastic surgeon. Hence, it is important to identify factors
associated with a poor aesthetic outcome after conventional
BCS, in order to determine which patients would benefit
the most from oncoplastic breast surgery. Potential risk fac-
tors for a poor aesthetic outcome, including tumour and
anthropometric characteristics, as well as treatment modal-
ities, have been studied previously [3–14]. However, patient
selection, sample size, studied factors, and ways to evaluate
outcome vary greatly between studies.
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Another intention when choosing BCS is to preserve
skin sensitivity in the operated breast. However, little is
known about potential determinants for impaired sensitiv-
ity in the breast skin or potential means to minimize this
disadvantage.
The aims of this prospective study were to examine
patient satisfaction concerning aesthetic result, includ-
ing symmetry, and skin sensitivity in the breast, in a
consecutive sample of patients undergoing conventional
BCS at a single institution, and to investigate potential
risk factors for low satisfaction.
Methods
Study cohort
Between February 1, 2008 and January 31, 2012, all patients
offered BCS at Skåne University Hospital, Malmö, due to
breast cancer or suspected malignancy, and able to compre-
hend information given in spoken and written Swedish
Fig. 1 Study cohort
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were eligible for inclusion in the present study. A total of
653 patients were identified as potential participants and
subsequently registered in the study database (Fig. 1).
Women operated with mastectomy were excluded (n =
108). A primary mastectomy was performed in 24 cases
on the patient’s request or due to cancer-related reasons,
whereas in 84 cases, the mastectomy was performed after
BCS due to histopathological findings, such as widespread
cancer in situ, multifocality, and/or non-radical margins
(n = 78), instead of re-excision (n = 4), or as a risk-
reducing procedure due to high-risk genes (n = 2). Other
reasons for exclusion were oncoplastic breast surgery
(n = 29), bilateral tumours (n = 5), previous breast can-
cer surgery in the same breast (n = 10), cancelled oper-
ation (n = 6), or lack of a consent form (n = 3). In total,
297 patients completed the questionnaire.
To examine the proportion of identified potential partic-
ipants in the study compared to all potentially eligible
patients, the material was compared retrospectively to the
Swedish Breast Cancer Registry. This is managed by the
six Regional Cancer Centres in Sweden through the Infor-
mation Network for Cancer Care (INCA), which reports a
very high inclusion rate (98.1%) [15]. It was found that
78% of potential participants had been registered for the
current study. Calculation details are presented in the sup-
plemental material (Additional file 1: p. 1-2; Figure S1).
Baseline examination
The attending surgeon performed the preoperative
examination. Height was measured to the closest half
centimetre. Weight was measured in kilogrammes to
one decimal place. Bilateral breast volume was measured
in millilitres, using specially designed and validated
plastic cups [16, 17]. Tumour size was measured in
millimetres. In cases of non-palpable tumours, the size
was established by ultrasound and/or mammography.
The location of the tumour was estimated to the closest
clock hour, in addition to the “central” position.
Surgery and adjuvant treatment
The surgeon chose operative method after discussing with
the patient. Breast-conserving surgery was generally
recommended to women diagnosed with a unifocal breast
tumour, less than 4 cm in diameter, if the surgeon
considered it possible to achieve an acceptable aesthetic
result. Oncoplastic breast surgery techniques were dis-
cussed in cases of a large tumour in relation to breast size.
Mobilization of breast tissue from the pectoral fascia
and overlying skin was routine. Non-palpable tumours
were localized by a hook-wire, placed with ultrasound or
stereotactic mammographic guidance before surgery. Six
breast surgeons performed 99% of the operations. The
sentinel node technique was routinely used in the examin-
ation of the axilla. A radioactive isotope (99mTc-Nanocoll)
with blue dye was injected near the tumour in all cases.
Sentinel nodes (1–3) were localized by a gamma detector
and/or the blue dye. They were surgically removed and
sent for frozen section analysis. If metastases were found,
an axillary clearance was performed.
In the operating theatre, a nurse weighed the excised
tissue to the closest gramme. The estimated percentage
of breast volume excised (EPBVE) was calculated by
comparing the specimen weight to the preoperative
breast volume, assuming a one to one correlation be-
tween weight and volume. This correlation has been
established in previous studies [6, 18, 19] and is consid-
ered to be a reasonable approximation for this study.
Chemotherapy, radiotherapy, and hormonal treatment
were given according to national guidelines [20]. No patient
received neoadjuvant chemotherapy. Adjuvant radiotherapy
was administered to the remaining breast parenchyma:
50 Gy per 25 fractions or 42.5 Gy per 16 fractions depend-
ing on patient age and tumour characteristics. Women
younger than 40 with invasive cancer received a 16 Gy boost
to the affected breast quadrant. No patient had brachyther-
apy. A subgroup of women (n = 20) had been enrolled in a
parallel ongoing trial, which studied the oncological out-
come of BCS without radiotherapy, for women over 65 years
of age. Patient charts were reviewed in order to determine
which adjuvant treatment had been administered.
Follow-up examinations and questionnaire
The surgeon examining the patient postoperatively
assessed complications. Evacuation of seromas and he-
matomas was noted. Infection was defined as the pres-
ence of clinical symptoms and administered antibiotics,
with or without a positive bacterial culture. Only infec-
tion was included in the analysis of outcome, due to the
Table 1 Patient satisfaction
Very satisfied n (%) Satisfied n (%) Not entirely satisfied n (%) Dissatisfied n (%) Missing n (%)
Aesthetic outcome 123 (41.4) 126 (42.4) 28 (9.4) 5 (1.7) 15 (5)
Symmetry 74 (24.9) 128 (43.1) 47 (15.8) 14 (4.7) 34 (11.4)
Skin sensitivity 82 (27.6) 117 (39.4) 65 (21.9) 8 (2.7) 25 (8.4)
Shape of op. breast 98 (33.0) 139 (46.8) 30 (10.1) 4 (1.3) 26 (8.8)
Size of op. breast 94 (31.6) 142 (47.8) 36 (12.1) 2 (0.7) 23 (7.7)
Appearance of scar 122 (41.1) 118 (40.0) 27 (9.0) 6 (2.0) 24 (8.1)
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Table 2 Satisfaction regarding aesthetic outcome
Factor Satisfied Not satisfied OR (95% CI) OR (95% CI)a OR (95% CI)b
n (%) n (%)
Age (years)
<50 42 (16.9) 4 (12.1) 1 1 1
≥50–<65 101 (40.6) 18 (54.5) 1.87 (0.60–5.86) 1.84 (0.58–5.78) 2.02 (0.61–6.71)
≥65 106 (42.6) 11 (33.3) 1.09 (0.33–3.61) 0.99 (0.30–3.32) 0.96 (0.27–3.38)
BMI (kg/m2)
<25 111 (44.5) 12 (36.4) 1 1 1
≥25–<30 83 (33.5) 13 (39.4) 1.45 (0.63–3.34) 1.58 (0.68–3.69) 1.57 (0.63–3.91)
≥30 54 (21.8) 8 (24.2) 1.37 (0.53–3.55) 1.49 (0.57–3.92) 1.68 (0.59–4.78)
Missing 1
Breast volume (ml)c
<500 107 (43.7) 14 (42.4) 1 1
≥500 138 (56.3) 19 (57.6) 1.05 (0.51–2.20) 1.02 (0.43–2.39)
Missing 4
Tumour size (mm)c
<15 120 (48.2) 14 (42.4) 1 1
≥15 129 (51.8) 19 (57.6) 1.26 (0.61–2.63) 1.16 (0.55–2.45)
Specimen weight (g)c
<63 127 (51.0) 11 (33.3) 1 1
≥63 122 (49.0) 22 (66.7) 2.08 (0.97–4.48) 2.15 (0.96–4.83)
EPBVEd (%)
<10 78 (31.8) 7 (21.2) 1 1 1
≥10–<20 137 (55.9) 16 (48.5) 1.30 (0.51–3.30) 1.29 (0.50–3.33) 1.14 (0.42–3.07)
≥20 30 (12.2) 10 (30.3) 3.71 (1.30–10.65) 3.93 (1.34–11.55) 3.05 (0.98–9.47)
Missing 4
Axillary clearance
No 212 (85.5) 22 (66.7) 1 1 1
Yes 36 (14.5) 11 (33.3) 2.94 (1.32–6.59) 3.02 (1.32–6.90) 2.87 (1.20–6.83)
Missing 1
Re-excision
No 234 (94.0) 28 (84.8) 1 1 1
Yes 15 (6.0) 5 (15.2) 2.79 (0.94–8.25) 3.09 (1.01–9.48) 3.02 (0.92–9.89)
Infection
No 235 (94.4) 28 (84.8) 1 1 1
Yes 14 (5.6) 5 (15.2) 3.00 (1.00–8.95) 2.92 (0.94–9.04) 2.65 (0.83–8.50)
Radiotherapy
No 37 (14.9) 3 (9.1) 1 1
Yes 212 (85.1) 30 (90.9) 1.75 (0.51–6.01) 1.48 (0.42–5.26)
Chemotherapy
No 220 (88.4) 29 (87.9) 1 1
Yes 29 (11.6) 4 (12.1) 1.05 (0.34–3.19) 1.10 (0.34–3.54)
Hormonal therapy
No 112 (45.0) 13 (39.4) 1 1
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lack of reliable data regarding other complications, apart
from those leading to surgery.
Patients were invited to follow-up approximately
1 year after the operation and completion of radiother-
apy. A trained nurse measured body weight and bilateral
breast volume, in the same way as was done preopera-
tively. The patients were handed a study-specific ques-
tionnaire in Swedish (translated version presented in the
supplemental material (Additional file 1: p. 3-4)), in which
they were asked to rate satisfaction concerning different
aspects of the aesthetic outcome (i.e. overall aesthetic out-
come, symmetry between the breasts, shape and size of
the operated breast, as well as appearance of the scar) and
skin sensitivity in the operated breast. The possible ratings
were dissatisfied (1), not entirely satisfied (2), satisfied (3),
or very satisfied (4). The clinicians who planned the study
constructed the questionnaire in consultation with a
psychologist. Readability was checked in a pilot test of five
women prior to the start of the study.
Statistical methods
Patient satisfaction was investigated in relation to pos-
sible determinants using logistic regression. Outcome
was dichotomized into “not satisfied” (1 + 2) or “satis-
fied” (3 + 4). Odds ratios (OR) were obtained, with 95%
confidence intervals (CI). The results were adjusted for
age and BMI. A final multivariable model included age
and BMI together with factors that were statistically
significant in either of the two previous models.
Continuous values were categorized into subgroups.
Tumour location, apart from the central position, was
grouped into quadrants, considering 12 o’clock to repre-
sent the upper outer quadrant.
Statistical analysis was performed using IBM SPSS®




Median age at the time of operation was 62 years
(interquartile range (IQR) 54–68) and median BMI was
26 kg/m2 (IQR 23–29). Median preoperative breast size
was 500 ml (IQR 375–737.5), tumour size 15 mm (IQR
10–20), specimen weight 63 g (IQR 45–91), and EPBVE
12.4% (IQR 9.2–17.1) (Additional file 1: Table S1). Infec-
tion was recorded in 23 (7.7%) cases. Ten patients re-
quired aspiration of seromas, and two hematomas were
evacuated. No operations caused by skin necrosis were
noted.
Patient satisfaction
The median time from operation to follow-up was
16 months (IQR 15–18). The proportion of women who
were satisfied or very satisfied with the overall aesthetic
result was 84%, regarding symmetry between the breasts,
it was 68%, and with skin sensitivity in the operated
breast it was 67% (Table 1).
Aesthetic outcome
An EPBVE ≥20%, axillary clearance, re-excision to obtain
clear margins, and postoperative infection increased the
risk of poor satisfaction regarding the overall aesthetic
result. Axillary clearance remained statistically significant
in the multivariable model (Table 2).
Symmetry
Obese patients (BMI ≥30 kg/m2), those with a specimen
weight exceeding 63 g, those who had undergone re-
excision, and patients subjected to postoperative infection
were less satisfied with symmetry between the breasts. Re-
excision remained statistically significant in the multivari-
able analysis (Table 3).
Table 2 Satisfaction regarding aesthetic outcome (Continued)
Yes 137 (55.0) 20 (60.6) 1.26 (0.60–2.64) 1.25 (0.59–2.66)
Quadrant
UOQ 127 (51.2) 20 (60.6) 1 1
LOQ 49 (19.8) 4 (12.1) 0.52 (0.17–1.61) 0.51 (0.16–1.57)
LIQ 20 (8.1) 4 (12.1) 1.30 (0.40–4.26) 1.29 (0.39–4.24)
UIQ 50 (20.2) 5 (15.2) 0.61 (0.22–1.73) 0.59 (0.21–1.67)
Central 2 (0.8) 0 (0.0) – –
Missing 1
aAdjusted for age and BMI. bAdjusted for age, BMI, EPBVE, axillary clearance, re-excision, and infection. cGroups divided at the median. dEstimated percentage of
breast volume excised
UOQ upper outer quadrant, LOQ lower outer quadrant, LIQ lower inner quadrant, UIQ upper inner quadrant
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Table 3 Satisfaction regarding symmetry between the breasts
Factor Satisfied Not satisfied OR (95% CI) OR (95% CI)a OR (95% CI)b
n (%) n (%)
Age (years)
<50 35 (17.3) 11 (18.0) 1 1 1
≥50–<65 83 (41.1) 26 (42.6) 1.00 (0.44–2.24) 0.97 (0.43–2.19) 0.93 (0.40–2.17)
≥65 84 (41.6) 24 (39.3) 0.91 (0.40–2.05) 0.77 (0.33–1.77) 0.70 (0.30–1.67)
BMI (kg/m2)
<25 95 (47.3) 20 (32.8) 1 1 1
≥25–<30 66 (32.8) 23 (37.7) 1.66 (0.84–3.26) 1.72 (0.87–3.42) 1.68 (0.82–3.44)
≥30 40 (19.9) 18 (29.5) 2.14 (1.02–4.46) 2.26 (1.07–4.80) 1.95 (0.85–4.48)
Missing 1
Breast volume (ml)c
<500 93 (46.5) 22 (36.1) 1 1
≥500 107 (53.5) 39 (63.9) 1.54 (0.85–2.79) 1.29 (0.65–2.55)
Missing 2
Tumour size (mm)c
<15 97 (48.0) 25 (41.0) 1 1
≥15 105 (52.0) 36 (59.0) 1.33 (0.75–2.38) 1.29 (0.71–2.34)
Specimen weight (g)c
<63 111 (55.0) 21 (34.4) 1 1 1
≥63 91 (45.0) 40 (65.6) 2.32 (1.28–4.22) 2.10 (1.12–3.94) 1.74 (0.90–3.34)
EPBVEd (%)
<10 66 (33.0) 16 (26.2) 1 1
≥10–<20 109 (54.5) 34 (55.7) 1.29 (0.66–2.51) 1.45 (0.73–2.88)
≥20 25 (12.5) 11 (18.0) 1.82 (0.74–4.44) 2.11 (0.84–5.29)
Missing 2
Axillary clearance
No 169 (84.1) 49 (80.3) 1 1
Yes 32 (15.9) 12 (19.7) 1.29 (0.62–2.70) 1.16 (0.55–2.48)
Missing 1
Re-excision
No 192 (95.0) 52 (85.2) 1 1 1
Yes 10 (5.0) 9 (14.8) 3.32 (1.28–8.60) 4.08 (1.53–10.88) 3.30 (1.19–9.14)
Infection
No 192 (95.0) 53 (86.9) 1 1 1
Yes 10 (5.0) 8 (13.1) 2.90 (1.09–7.71) 2.55 (0.93–6.99) 2.51 (0.91–6.98)
Radiotherapy
No 28 (13.9) 5 (8.2) 1 1
Yes 174 (86.1) 56 (91.8) 1.80 (0.66–4.89) 1.82 (0.65–5.10)
Chemotherapy
No 178 (88.1) 54 (88.5) 1 1
Yes 24 (11.9) 7 (11.5) 0.96 (0.39–2.35) 0.87 (0.34–2.23)
Hormonal therapy
No 95 (47.0) 21 (34.4) 1 1
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Skin sensitivity
Factors associated with poor patient satisfaction with
skin sensitivity in the breast were BMI ≥25–<30 kg/
m2, tumour size ≥15 mm, EPBVE ≥20%, axillary clear-
ance, re-excision, radiotherapy, and infection. Multi-
variable analysis showed that BMI ≥25–<30 kg/m2,
tumour size ≥15 mm, re-excision, and infection were
independent risk factors (Table 4).
Shape and size of the operated breast and visual
appearance of the scar
Women with a BMI ≥25–<30 kg/m2 and those with an
EPBVE ≥20% were less satisfied with the shape of the
operated breast. Axillary clearance was associated with
poor satisfaction with the size of the operated breast, but
the association did not remain statistically significant after
adjustment. A BMI ≥30 kg/m2 and an EPBVE ≥20%
were associated with less satisfaction regarding the
size of the operated breast, but the results were only
statistically significant in the adjusted models. Patients
with an EPBVE ≥20% were less satisfied with the scar
(Additional file 1: Tables S2–S4).
Discussion
An EPBVE ≥20%, a BMI ≥25 kg/m2, axillary clearance,
re-excision, and infection were associated with low satis-
faction regarding several aspects of the aesthetic result
after conventional BCS. Regarding skin sensitivity in the
breast, a BMI ≥25–<30 kg/m2, tumour size ≥15 mm, an
EPBVE ≥20%, axillary clearance, re-excision, radiother-
apy, and infection seemed to have had a negative impact.
Aesthetic result
The great majority (84%) of patients were satisfied or
very satisfied with the overall aesthetic result, which is in
line with previous studies. Patient ratings as “excellent”
or “good” were reported by Johansen et al. in 73%, by
Taylor et al. in 87%, and by Cetintas et al. in 84%.
Sneeuw et al. reported a rate of “very satisfied” in 59%
and “little satisfied” in 30% [5, 9, 11, 21].
Age did not seem to influence patient satisfaction. This
confirms results from some previous studies [5, 7, 9],
whereas others have shown that both younger [13, 14]
and older age [5, 11] can increase the risk of poor out-
come. In these studies, age groups have been defined dif-
ferently, but most studies have had a cutoff at 60 years to
define “younger” and “older”. It could be hypothesized
that a potential negative impact of high age on aesthetic
outcome could be concealed by less favourable ratings
from younger women, with possibly higher demands
regarding the aesthetic result. In a study by Cetintas et al.,
age >50 years was shown to be a risk factor for poor
aesthetic outcome when the evaluation of outcome was
made by a panel of observers, but not when the patients
evaluated the results [5].
Obesity (BMI ≥30 kg/m2) seemed to increase the risk
of the patient not being satisfied with symmetry, as did
re-excision. These results are in accordance with a study
by Waljee et al. [13].
Tumour and breast size were not associated with patient
satisfaction regarding aesthetic outcome in our study.
Other studies have shown either no influence [3, 5, 9] or a
negative influence [13] of larger tumour sizes on outcome.
Most studies have shown a correlation between high
specimen weight and worse aesthetic result [7, 11, 12].
However, the extent of excised tissue should be related to
preoperative breast volume. Some studies have used bra
cup size to estimate breast size [13], which is an imprecise
measurement [22]. Bulstrode et al. [23] and Cochrane et
al. [6] used mammography measurements, which im-
proved accuracy. However, this method requires access to
mammograms, applicable software, and calculation of
breast volume. In our study, the estimation of breast
volume was made using plastic cups, which are routinely
used in our department. This is a valid method, with
acceptable reliability, and is readily available in the clinical
setting [17]. Our results indicate that an EPBVE exceeding
20% is a risk factor for poor outcome regarding several
aspects of aesthetic outcome, which is in line with the
studies mentioned above.
Table 3 Satisfaction regarding symmetry between the breasts (Continued)
Yes 107 (53.0) 40 (65.6) 1.69 (0.93–3.07) 1.69 (0.92–3.10)
Quadrant
UOQ 101 (50.0) 35 (58.3) 1 1
LOQ 40 (19.8) 10 (16.7) 0.72 (0.33–1.59) 0.67 (0.30–1.51)
LIQ 17 (8.4) 6 (10.0) 1.02 (0.37–2.79) 1.08 (0.39–3.02)
UIQ 42 (20.8) 10 (15.0) 0.62 (0.27–1.40) 0.60 (0.26–1.37)
Central 2 (1.0) 0 (0.0) – –
Missing 1
aAdjusted for age and BMI. bAdjusted for age, BMI, specimen weight, re-excision, and infection. cGroups divided at the median. dEstimated percentage of breast
volume excised
UOQ upper outer quadrant, LOQ lower outer quadrant, LIQ lower inner quadrant, UIQ upper inner quadrant
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Table 4 Satisfaction regarding skin sensitivity in the operated breast
Factor Satisfied Not satisfied OR (95% CI) OR (95% CI)a OR (95% CI)b
n (%) n (%)
Age (years)
<50 33 (16.6) 13 (17.8) 1 1 1
≥50–<65 78 (39.2) 36 (49.3) 1.17 (0.55–2.49) 1.15 (0.54–2.48) 1.15 (0.49–2.71)
≥65 88 (44.2) 24 (32.9) 0.69 (0.32–1.52) 0.61 (0.27–1.36) 0.59 (0.25–1.44)
BMI (kg/m2)
<25 93 (47.0) 26 (35.6) 1 1 1
≥25–<30 62 (31.3) 31 (42.5) 1.79 (0.97–3.30) 1.99 (1.06–3.72) 2.07 (1.04–4.12)
≥30 43 (21.7) 16 (21.9) 1.33 (0.65–2.73) 1.51 (0.72–3.16) 1.78 (0.78–4.03)
Missing 1
Breast volume (ml)c
<500 88 (44.7) 31 (43.1) 1 1
≥500 109 (55.3) 41 (56.9) 1.07 (0.62–1.84) 1.05 (0.56–1.98)
Missing 2 1
Tumour size (mm)c
<15 106 (53.3) 22 (30.1) 1 1 1
≥15 93 (46.7) 51 (69.9) 2.64 (1.49–4.68) 2.43 (1.36–4.34) 1.88 (1.01–3.48)
Specimen weight (g)c
<63 106 (53.3) 30 (41.1) 1 1
≥63 93 (46.7) 43 (58.9) 1.63 (0.95–2.81) 1.65 (0.92–2.94)
EPBVEd (%)
<10 67 (34.0) 17 (23.6) 1 1 1
≥10–<20 107 (54.3) 40 (55.6) 1.47 (0.77–2.81) 1.49 (0.77–2.90) 1.15 (0.56–2.36)
≥20 23 (11.7) 15 (20.8) 2.57 (1.11–5.96) 2.80 (1.18–6.65) 1.84 (0.73–4.63)
Missing 2 1
Axillary clearance
No 171 (85.9) 53 (73.6) 1 1 1
Yes 28 (14.1) 19 (26.4) 2.19 (1.13–4.23) 2.07 (1.05–4.07) 1.57 (0.75–3.28)
Missing 1
Re-excision
No 191 (96.0) 63 (86.3) 1 1 1
Yes 8 (4.0) 10 (13.7) 3.80 (1.43–10.02) 4.14 (1.53–11.20) 3.86 (1.34–11.06)
Infection
No 190 (95.5) 63 (86.3) 1 1 1
Yes 9 (4.5) 10 (13.7) 3.35 (1.30–8.62) 3.58 (1.34–9.60) 3.26 (1.18–9.03)
Radiotherapy
No 32 (16.1) 5 (5.5) 1 1 1
Yes 167 (83.9) 69 (94.5) 3.31 (1.13–9.70) 2.87 (0.96–8.61) 1.73 (0.53–5.68)
Chemotherapy
No 180 (90.5) 60 (82.2) 1 1
Yes 19 (9.5) 13 (17.8) 2.05 (0.96–4.41) 1.94 (0.86–4.36)
Hormonal therapy
No 94 (47.2) 26 (35.6) 1 1
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The location of the tumour did not seem to affect
patient satisfaction. However, some subgroups consisted
of very few patients, making it difficult to achieve statis-
tical power. Some previous studies have shown a worse
aesthetic outcome with tumours located medially or in
the lower quadrants [12–14], while others have shown
no difference [3–5, 7, 9].
In this study, axillary clearance appeared to be a strong
determinant for poor satisfaction regarding overall
aesthetic result, and remained statistically significant in
the multivariable model. This contradicts studies showing
no influence of the extent of axillary surgery on aesthetic
outcome [3, 7, 11]. However, some previous studies have
noted an effect of axillary surgery on the breast. Beadle et
al. reported that while axillary clearance had not influ-
enced overall aesthetic results, it did increase the risk of
breast oedema up to over a year postoperatively [3]. In this
study, there were unfortunately no reliable data concern-
ing postoperative lymphedema, a condition which is likely
to have had a negative impact on satisfaction. Another
possible way for axillary clearance to impact the aesthetic
outcome of the breast is if the axillary scar pulls the upper
lateral quadrant up towards the axilla.
Radiotherapy seemed to negatively influence many
aspects of the aesthetic outcome in our study, but the results
were not statistically significant. However, some subgroups
consisted of very few patients. Radiotherapy may impact the
aesthetic outcome by influence on skin colour and changes
in breast tissue, such as increased breast fibrosis. Several
previous studies have shown a negative influence of radio-
therapy on aesthetic results [3, 11, 12].
Chemotherapy and hormonal therapy were not associ-
ated with patient satisfaction in this study. Some previ-
ous studies have shown no influence of chemotherapy
on aesthetic outcome [24], whereas others have shown
that both sequential [8] and concomitant [11] chemo-
therapy may have a negative impact. Treatment with
tamoxifen has not been shown to influence aesthetic
results in previous studies, in accordance with our
results [4, 5, 8, 11, 24, 25].
Skin sensitivity
In regard to skin sensitivity in the operated breast, 67%
were satisfied or very satisfied. In a study by Hau et al.,
77% reported excellent/good/normal sensitivity vs. 23%
fair/poor. These patients rated sensitivity 5 years postoper-
atively, which could explain the higher satisfaction rate.
Hau et al. showed a correlation between impairment of
breast sensitivity and worse quality of life (QoL) [26].
A BMI ≥25–<30 kg/m2, tumour size ≥15 mm, an EPBVE
≥20%, axillary clearance, re-excision, radiotherapy, and in-
fection, seem to have negatively influenced patient satisfac-
tion regarding skin sensitivity after conventional BCS in this
study. Independent risk factors in the multivariable analysis
were BMI, tumour size, re-excision, and infection. It is in-
teresting that BMI ≥25–<30 kg/m2 seemed to be a risk fac-
tor, but not a BMI ≥30. An explanation for this could be
that women with larger breasts may have experienced poor
sensitivity in the breasts preoperatively. Previous studies
have shown that breast reduction procedures can improve
skin sensitivity in women with very large breasts [27].
To our knowledge, there are no previous studies investi-
gating potential determinants influencing skin sensitivity
after BCS. This may partly be caused by the fact that skin
sensitivity in the breast is seldom studied exclusively, but
is more often incorporated in an overall QoL score [9, 26].
Techniques of oncoplastic breast surgery are being more
widely used. It could be hypothesized that more extensive
mobilization or rearrangement of breast tissue could have a
negative impact on skin sensitivity. This could be one reason
for surgeons to advise against use of more advanced tech-
niques. However, as we have shown, also in conventional
BCS, patients can experience impaired skin sensitivity in the
operated breast. Further studies to investigate this are needed
in order to gain more knowledge, which could aid decision-
making regarding which surgical technique to choose, and
enhance the accuracy of information given to patients.
Study strengths and limitations
The strengths of this study are the size of the study popu-
lation and the prospective approach, with standardized
Table 4 Satisfaction regarding skin sensitivity in the operated breast (Continued)
Yes 105 (52.8) 47 (64.4) 1.62 (0.93–2.82) 1.56 (0.89–2.74)
Quadrant
UOQ 103 (52.0) 36 (49.3) 1 1
LOQ 39 (19.7) 14 (19.2) 1.03 (0.50–2.11) 1.03 (0.49–2.15)
LIQ 16 (8.1) 7 (9.6) 1.25 (0.48–3.29) 1.37 (0.51–3.69)
UIQ 38 (19.2) 16 (21.9) 1.21 (0.60–2.42) 1.13 (0.56–2.30)
Central 2 (1.0) 0 (0.0) – –
Missing 1
aAdjusted for age and BMI. bAdjusted for age, BMI, tumour size, EPBVE, axillary clearance, re-excision, and infection. cGroups divided at the median. dEstimated
percentage of breast volume excised
UOQ upper outer quadrant, LOQ lower outer quadrant, LIQ lower inner quadrant, UIQ upper inner quadrant
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measurements of tumour and anthropometric characteris-
tics. Follow-up took place approximately 1 year after sur-
gery and completion of radiotherapy, making it possible to
study the effects of adjuvant therapy on outcome.
The main weakness of the study is that a fairly large
proportion of the study population was lost in follow-
up. This was partly caused by limited resources in the
out-patient clinic during certain time periods, inhibiting
invitations to follow-up. To investigate potential selec-
tion bias, participants and non-participants were com-
pared (Additional file 1: Table S4). The characteristics
are very similar, and we consider the material to be a
representative study sample.
It has been difficult to define surgical techniques more
precisely since several surgeons were involved, each decid-
ing how much mobilization was needed in the individual
patient. However, the aim of this study was not to com-
pare surgical techniques, but to identify risk factors for an
unsatisfying result after conventional BCS in general.
Complications, other than infection, may have influ-
enced satisfaction in the individual patient. However, there
were very few serious complications and it is unlikely that
they would have had any significant impact on the results
of the study population in general. Previous breast cancer
surgery on the opposite breast could influence satisfaction
with symmetry. A sensitivity analysis excluding 16 patients
to which this applied was performed (Additional file 1:
Table S5). The results were similar. However, in this ana-
lysis, a statistically significant association between adju-
vant hormonal therapy and low satisfaction was observed.
It could be hypothesized that a potential impact of hormo-
nal therapy on patient weight and breast size would not
cause as much asymmetry in patients who had undergone
surgery and radiotherapy bilaterally, since the breasts
would react similarly to weight fluctuations.
Conclusions
This study supports previously published recommenda-
tions presenting a maximum limit of 20% breast volume
excision with conventional BCS [22]. If the excision is
estimated to exceed this, oncoplastic breast surgery or
mastectomy with reconstruction might be more suitable
surgical approaches to offer the patient.
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